Cell-sized lipid vesicles for cell-cell synaptic therapies.

about

Cell-sized lipid vesicles for cell-cell synaptic therapies.

Item

http://www.wikidata.org/entity/Q55017639

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cell-sized lipid vesicles for cell-cell synaptic therapies.

@en

Cell-sized lipid vesicles for cell-cell synaptic therapies.

@nl

type

Item

label

Cell-sized lipid vesicles for cell-cell synaptic therapies.

@en

Cell-sized lipid vesicles for cell-cell synaptic therapies.

@nl

prefLabel

Cell-sized lipid vesicles for cell-cell synaptic therapies.

@en

Cell-sized lipid vesicles for cell-cell synaptic therapies.

@nl

P1476

Cell-sized lipid vesicles for cell-cell synaptic therapies

@en

P2093

A P Lee

http://www.w3.org/2001/XMLSchema#string

C Rapier

http://www.w3.org/2001/XMLSchema#string

C Zhang

http://www.w3.org/2001/XMLSchema#string

D Lee

http://www.w3.org/2001/XMLSchema#string

S D Chessler

http://www.w3.org/2001/XMLSchema#string

S H Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Transcellular neuroligin-2 interactions enhance insulin secretion and are integral to pancreatic β cell function

Neurexin-1α contributes to insulin-containing secretory granule docking

Neurexin mediates the assembly of presynaptic terminals

Microfluidic generation of acoustically active nanodroplets.

High-speed, clinical-scale microfluidic generation of stable phase-change droplets for gas embolotherapy.

Controllable microfluidic synthesis of multiphase drug-carrying lipospheres for site-targeted therapy

Forming giant vesicles with controlled membrane composition, asymmetry, and contents.

Impact of membrane-anchored fluorescent probes on the mechanical properties of lipid bilayers.

In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer.

Beta-granule transport and exocytosis.

P304

201-213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1142/S233954781750011X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Derek Vallejo

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29744376

http://www.w3.org/2001/XMLSchema#string

P932

5937847

http://www.w3.org/2001/XMLSchema#string